Progesterone News and Research

RSS

UCLA study shows progesterone can be used as therapy for endometrial cancer

Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.

11 Jun 2013

Potential new treatment approaches for liver diseases

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

24 May 2013

March of Dimes, Ohio research centers and hospitals establish new research program to prevent preterm birth

Three major Ohio universities and four hospitals have joined with the March of Dimes Foundation to establish a new collaborative research program aimed exclusively at finding the unknown causes of premature birth.

22 May 2013

Study: 3/4 women experience constipation and other bowel disorders during their pregnancies

Nearly three out of four pregnant women experience constipation, diarrhea or other bowel disorders during their pregnancies, a Loyola University Medical Center study has found.

21 May 2013

Research: Women's reproductive function may be tied to their immune status

New research indicates that women's reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females.

18 May 2013

Columbia Laboratories net revenues increase 65% to $6.3 million in first quarter 2013

Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2013.

9 May 2013

Researchers identify gene variations linked to male and female infertility

Identification of genetic variations in the genes coding for the hormone FSH may provide new treatments for male and female infertility, according to work presented at the European Congress of Endocrinology in Copenhagen.

30 Apr 2013

Hormones regulate sexual desire in women

Feeling frisky? If so, chances are greater your estrogen level -- and, perhaps, fertility -- are hitting their monthly peak. If not, you're more likely experiencing a profusion of desire-deadening progesterone, and the less fertile time in your cycle.

26 Apr 2013

Promising development for women with triple-negative breast cancer

Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer.

24 Apr 2013

Phase III clinical trial data of Milprosa vaginal ring presented at PCRS annual meeting

Teva Pharmaceutical Industries Ltd. today presented data from a sub-analysis of a Phase III clinical trial of Milprosa (progesterone) vaginal ring, an investigational, once-weekly therapy for luteal phase support in women undergoing in vitro fertilization.

18 Apr 2013

Androgen receptors found to be a potential target in breast cancer

Estrogen and progesterone receptors, and the gene HER2 - these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.

11 Apr 2013

Research shows omega-3 fatty acids stop proliferation of triple-negative breast cancer cells

Researchers from Fox Chase Cancer Center have found that omega-3 fatty acids and their metabolite products slow or stop the proliferation, or growth in the number of cells, of triple-negative breast cancer cells more effectively than cells from luminal types of the disease.

10 Apr 2013

New study shows some women don't stick to recommended treatment for breast cancer

One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.

10 Apr 2013

Columbia Laboratories amends license, supply agreement with Merck Serono for CRINONE

Columbia Laboratories, Inc. has amended its license and supply agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for CRINONE (progesterone gel) through May 2020, representing an extension of five years beyond the current term, which was due to expire in May 2015.

10 Apr 2013

Overexpression of miR-155 promotes growth of blood vessels in tumors and metastasis

Researchers at Moffitt Cancer Center have determined that the overexpression of microRNA-155 (miR-155), a short, single strand of ribonucleic acid encoded by the miR-155 host gene, promotes the growth of blood vessels in tumors, tumor inflammation, and metastasis.

4 Apr 2013

Progesterone News and Research

UCLA study shows progesterone can be used as therapy for endometrial cancer

Potential new treatment approaches for liver diseases

March of Dimes, Ohio research centers and hospitals establish new research program to prevent preterm birth

Study: 3/4 women experience constipation and other bowel disorders during their pregnancies

Research: Women's reproductive function may be tied to their immune status

Columbia Laboratories net revenues increase 65% to $6.3 million in first quarter 2013

Researchers identify gene variations linked to male and female infertility

Hormones regulate sexual desire in women

Promising development for women with triple-negative breast cancer

Phase III clinical trial data of Milprosa vaginal ring presented at PCRS annual meeting

Androgen receptors found to be a potential target in breast cancer

Research shows omega-3 fatty acids stop proliferation of triple-negative breast cancer cells

New study shows some women don't stick to recommended treatment for breast cancer

Columbia Laboratories amends license, supply agreement with Merck Serono for CRINONE

Overexpression of miR-155 promotes growth of blood vessels in tumors and metastasis

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Study suggests possibility of engineering artificial ovaries in lab

Abiraterone's anti-androgenic properties may stop tumor growth of CRPC, says prize-winning Dutch study

Scientist awarded $1.2M grant to develop therapy to reduce premature births

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News